Multi-targeted approach by 2-benzimidazolylquinoxalines-loaded cationic arginine liposomes against сervical cancer cells in vitro.

[1]  A. Chilkoti,et al.  Long circulating genetically encoded intrinsically disordered zwitterionic polypeptides for drug delivery. , 2019, Biomaterials.

[2]  A. Detappe,et al.  Advancements in Nanomedicine for Multiple Myeloma. , 2018, Trends in molecular medicine.

[3]  G. Storm,et al.  Towards clinical translation of ligand‐functionalized liposomes in targeted cancer therapy: Challenges and opportunities , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Shyh-Dar Li,et al.  Cancer theranostic applications of lipid-based nanoparticles. , 2018, Drug discovery today.

[5]  Khaled Seidi,et al.  Tumor target amplification: Implications for nano drug delivery systems , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[6]  M. Gómez-Guillén,et al.  Encapsulation of food waste compounds in soy phosphatidylcholine liposomes: Effect of freeze-drying, storage stability and functional aptitude , 2018 .

[7]  Richard L. Nolan,et al.  Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases , 2018, Pharmacological research.

[8]  T. Khan,et al.  PhytoNanotechnology: Enhancing Delivery of Plant Based Anti-cancer Drugs , 2018, Front. Pharmacol..

[9]  Reena Gupta,et al.  Prodrugs, phospholipids and vesicular delivery - An effective triumvirate of pharmacosomes. , 2018, Advances in colloid and interface science.

[10]  Muhammad Adil Riaz,et al.  Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review , 2018, International journal of molecular sciences.

[11]  T. Osaki,et al.  Bleomycin-Loaded pH-Sensitive Polymer–Lipid-Incorporated Liposomes for Cancer Chemotherapy , 2018, Polymers.

[12]  L. Zakharova,et al.  Synthesis, Self-Association, and Solubilizing Ability of an Amphiphilic Derivative of Poly(ethylene glycol) Methyl Ether , 2017, Russian Journal of General Chemistry.

[13]  Timothy W. Secomb,et al.  Transport of drugs from blood vessels to tumour tissue , 2017, Nature Reviews Cancer.

[14]  K. Ewert,et al.  Distinct solubility and cytotoxicity regimes of paclitaxel-loaded cationic liposomes at low and high drug content revealed by kinetic phase behavior and cancer cell viability studies. , 2017, Biomaterials.

[15]  A. Haeri,et al.  State of the Art of Stimuli-Responsive Liposomes for Cancer Therapy , 2017, Iranian journal of pharmaceutical research : IJPR.

[16]  N. Zhukova,et al.  Advances in the synthesis of benzimidazol-2-ones , 2017 .

[17]  A. Degterev,et al.  Targeting energy metabolism of cancer cells: Combined administration of NCL-240 and 2-DG. , 2017, International journal of pharmaceutics.

[18]  Huacan Song,et al.  Study on the design, synthesis and structure-activity relationships of new thiosemicarbazone compounds as tyrosinase inhibitors. , 2017, European journal of medicinal chemistry.

[19]  A. Zeb,et al.  Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors , 2017, International journal of nanomedicine.

[20]  L. Zakharova,et al.  Surfactant solutions for enhancing solubility of new arylquinolin-2-ones , 2017 .

[21]  V. Bulmus,et al.  Effect of Molecular Architecture on Cell Interactions and Stealth Properties of PEG. , 2017, Biomacromolecules.

[22]  Rachael M. Crist,et al.  Zeta potential: a case study of cationic, anionic, and neutral liposomes , 2017, Analytical and Bioanalytical Chemistry.

[23]  Francesco Castelli,et al.  Interaction between PEG lipid and DSPE/DSPC phospholipids: An insight of PEGylation degree and kinetics of de-PEGylation. , 2017, Colloids and surfaces. B, Biointerfaces.

[24]  Limin Mu,et al.  Lipid vesicles containing transferrin receptor binding peptide TfR-T12 and octa-arginine conjugate stearyl-R8 efficiently treat brain glioma along with glioma stem cells , 2017, Scientific Reports.

[25]  S. Futaki,et al.  Arginine-rich cell-penetrating peptide-modified extracellular vesicles for active macropinocytosis induction and efficient intracellular delivery , 2018 .

[26]  P. Masson,et al.  Nanoparticle-Delivered 2-PAM for Rat Brain Protection against Paraoxon Central Toxicity. , 2017, ACS applied materials & interfaces.

[27]  Alibakhsh Kasaeian,et al.  Biomimetics in drug delivery systems: A critical review , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[28]  Benjamin R. Lee,et al.  Focused Ultrasound-Triggered Release of Tyrosine Kinase Inhibitor From Thermosensitive Liposomes for Treatment of Renal Cell Carcinoma. , 2017, Journal of pharmaceutical sciences.

[29]  H. Harashima,et al.  Modality of tumor endothelial VEGFR2 silencing‐mediated improvement in intratumoral distribution of lipid nanoparticles , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[30]  O. Inanami,et al.  Lipophilic triphenylphosphonium derivatives enhance radiation-induced cell killing via inhibition of mitochondrial energy metabolism in tumor cells. , 2017, Cancer letters.

[31]  K. Hynynen,et al.  To heat or not to heat: Challenges with clinical translation of thermosensitive liposomes , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[32]  Takashi Nakamura,et al.  Modifying Cationic Liposomes with Cholesteryl-PEG Prevents Their Aggregation in Human Urine and Enhances Cellular Uptake by Bladder Cancer Cells. , 2017, Biological & pharmaceutical bulletin.

[33]  Giuseppe Toffoli,et al.  Nanocarriers in cancer clinical practice: a pharmacokinetic issue. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[34]  S. Mehdi,et al.  Therapeutic evolution of benzimidazole derivatives in the last quinquennial period. , 2017, European journal of medicinal chemistry.

[35]  Xun Sun,et al.  Development of a multi-target peptide for potentiating chemotherapy by modulating tumor microenvironment. , 2016, Biomaterials.

[36]  L. Zakharova,et al.  Self-assembly strategy for the design of soft nanocontainers with controlled properties , 2016 .

[37]  T. Ishida,et al.  Improvement of intratumor microdistribution of PEGylated liposome via tumor priming by metronomic S-1 dosing , 2016, International journal of nanomedicine.

[38]  C. Luo,et al.  Discovery of 3-(5'-Substituted)-Benzimidazole-5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazoles as Potent Fibroblast Growth Factor Receptor Inhibitors: Design, Synthesis, and Biological Evaluation. , 2016, Journal of medicinal chemistry.

[39]  D. Richardson,et al.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come , 2016, Pharmacological Reviews.

[40]  Dan Wu,et al.  N-Phenyl indole derivatives as AT1 antagonists with anti-hypertension activities: Design, synthesis and biological evaluation. , 2016, European journal of medicinal chemistry.

[41]  L. Pérez,et al.  New cationic vesicles prepared with double chain surfactants from arginine: Role of the hydrophobic group on the antimicrobial activity and cytotoxicity. , 2016, Colloids and surfaces. B, Biointerfaces.

[42]  V. Mamedov.  Recent advances in the synthesis of benzimidazol(on)es via rearrangements of quinoxalin(on)es , 2016 .

[43]  V. Mamedov.  Quinoxalines: Synthesis, Reactions, Mechanisms and Structure , 2016 .

[44]  U. Farooq,et al.  Synthesis, structure–activity relationship and antinociceptive activities of some 2-(2′-pyridyl) benzimidazole derivatives , 2016, Medicinal Chemistry Research.

[45]  M. Mateescu,et al.  The fungicide thiabendazole causes apoptosis in rat hepatocytes. , 2016, Toxicology in vitro : an international journal published in association with BIBRA.

[46]  A. Degterev,et al.  Cytotoxicity of PEGylated liposomes co-loaded with novel pro-apoptotic drug NCL-240 and the MEK inhibitor cobimetinib against colon carcinoma in vitro. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[47]  Dinesh Kumar,et al.  Micellar carriers for the delivery of multiple therapeutic agents. , 2015, Colloids and surfaces. B, Biointerfaces.

[48]  Rangappa S. Keri,et al.  Comprehensive Review in Current Developments of Benzimidazole‐Based Medicinal Chemistry , 2015, Chemical biology & drug design.

[49]  M. Cordeiro,et al.  Quinoxaline, its derivatives and applications: A State of the Art review. , 2015, European journal of medicinal chemistry.

[50]  K. Kono,et al.  PAMAM Dendron Lipid Assemblies That Undergo Structural Transition in Response to Weakly Acidic pH and Their Cytoplasmic Delivery Capability. , 2015, Langmuir : the ACS journal of surfaces and colloids.

[51]  A. Molinari,et al.  Liposomes as nanomedical devices , 2015, International journal of nanomedicine.

[52]  Haijia Su,et al.  Safe and efficient pH sensitive tumor targeting modified liposomes with minimal cytotoxicity. , 2014, Colloids and surfaces. B, Biointerfaces.

[53]  M. Infante,et al.  Cationic vesicles based on biocompatible diacyl glycerol-arginine surfactants: physicochemical properties, antimicrobial activity, encapsulation efficiency and drug release. , 2014, Colloids and surfaces. B, Biointerfaces.

[54]  B. Nair,et al.  Bibenzimidazole containing mixed ligand cobalt(III) complex as a selective receptor for iodide , 2014 .

[55]  C. Hulme,et al.  Novel succinct routes to Quinoxalines and 2-Benzimidazolylquinoxalines via the Ugi reaction. , 2014, Tetrahedron letters.

[56]  Okhil K. Nag,et al.  Surface Engineering of Liposomes for Stealth Behavior , 2013, Pharmaceutics.

[57]  S. Pastorino,et al.  High-efficiency liposomal encapsulation of a tyrosine kinase inhibitor leads to improved in vivo toxicity and tumor response profile , 2013, International journal of nanomedicine.

[58]  V. Cardile,et al.  Evaluation of new amphiphilic PEG derivatives for preparing stealth lipid nanoparticles , 2013 .

[59]  S. Mobin,et al.  Influence of ancillary ligands on the electronic structure and anion sensing features of ligand bridged diruthenium complexes. , 2013, Dalton transactions.

[60]  E. Vodovozova,et al.  Nano-sized melphalan and sarcolysine drug delivery systems: synthesis and prospects of application , 2013 .

[61]  Xiaoming Zhang,et al.  Liposomes as vehicles for lutein: preparation, stability, liposomal membrane dynamics, and structure. , 2013, Journal of agricultural and food chemistry.

[62]  V. Torchilin,et al.  Current trends in the use of liposomes for tumor targeting. , 2013, Nanomedicine.

[63]  E. De Clercq,et al.  Coumarins hinged directly on benzimidazoles and their ribofuranosides to inhibit hepatitis C virus. , 2013, European journal of medicinal chemistry.

[64]  K. Holmberg,et al.  Solubilization of Hydrophobic Dyes in Surfactant Solutions , 2013, Materials.

[65]  Alexander Levitzki,et al.  Tyrosine kinase inhibitors: views of selectivity, sensitivity, and clinical performance. , 2013, Annual review of pharmacology and toxicology.

[66]  Y. Bansal,et al.  The therapeutic journey of benzimidazoles: a review. , 2012, Bioorganic & medicinal chemistry.

[67]  H. Kasukawa,et al.  Comparative studies of polyethylene glycol-modified liposomes prepared using different PEG-modification methods. , 2012, Biochimica et biophysica acta.

[68]  P. Singare,et al.  Cationic Surfactants from Arginine: Synthesis and Physicochemical Properties , 2012 .

[69]  G. Hegde,et al.  Synthesis, characterization and antimicrobial studies of some new quinoline incorporated benzimidazole derivatives. , 2012, European journal of medicinal chemistry.

[70]  W. Hennink,et al.  Tumor-targeted Nanobullets: Anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[71]  A. Natarajan,et al.  Perturbing pro-survival proteins using quinoxaline derivatives: a structure-activity relationship study. , 2012, Bioorganic & medicinal chemistry.

[72]  W. Berger,et al.  A SAR study of novel antiproliferative ruthenium and osmium complexes with quinoxalinone ligands in human cancer cell lines. , 2012, Journal of medicinal chemistry.

[73]  Chong-K. Kim,et al.  Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[74]  Yan Zhang,et al.  The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells. , 2011, Biomaterials.

[75]  V. Mamedov,et al.  Recyclization reactions leading to benzimidazoles , 2011 .

[76]  Jian Zhang,et al.  Physical and chemical stability of drug nanoparticles. , 2011, Advanced drug delivery reviews.

[77]  W. Vaz,et al.  In Vitro Surfactant Structure-Toxicity Relationships: Implications for Surfactant Use in Sexually Transmitted Infection Prophylaxis and Contraception , 2011, PloS one.

[78]  M. Infante,et al.  Amino Acids as Raw Material for Biocompatible Surfactants , 2011 .

[79]  M. Babaei,et al.  Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[80]  G. Kempter,et al.  Chinoxaline durch Eintopfreaktion von 3‐Hydroxyiminobutan‐2‐on, Brom und o‐Phenylendiamin , 2010 .

[81]  U. Schubert,et al.  Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. , 2010, Angewandte Chemie.

[82]  D. Erdmann,et al.  Potent and Selective Inhibition of Polycythemia by the Quinoxaline JAK2 Inhibitor NVP-BSK805 , 2010, Molecular Cancer Therapeutics.

[83]  P. Wipf,et al.  Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library. , 2009, Assay and drug development technologies.

[84]  S. Yıldız,et al.  Synthesis and antiparasitic and antifungal evaluation of 2'-arylsubstituted-1H,1'H-[2,5']bisbenzimidazolyl-5-carboxamidines. , 2009, European journal of medicinal chemistry.

[85]  Peter Wipf,et al.  Development of a 384-well colorimetric assay to quantify hydrogen peroxide generated by the redox cycling of compounds in the presence of reducing agents. , 2008, Assay and drug development technologies.

[86]  R. Yunes,et al.  Ester derivatives of gallic acid with potential toxicity toward L1210 leukemia cells. , 2008, Bioorganic & medicinal chemistry.

[87]  Sam Michael,et al.  Dual-fluorophore quantitative high-throughput screen for inhibitors of BRCT-phosphoprotein interaction. , 2008, Analytical biochemistry.

[88]  J. Janc,et al.  Generation of potent coagulation protease inhibitors utilizing zinc-mediated chelation. , 2006, Bioorganic & medicinal chemistry letters.

[89]  E. Novellino,et al.  2-(Benzimidazol-2-yl)quinoxalines: a novel class of selective antagonists at human A(1) and A(3) adenosine receptors designed by 3D database searching. , 2005, Journal of medicinal chemistry.

[90]  Tun-Cheng Chien,et al.  Synthesis and antiviral evaluation of polyhalogenated imidazole nucleosides: dimensional analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole. , 2004, Journal of medicinal chemistry.

[91]  S. Anzali,et al.  Halothiophene benzimidazoles as P1 surrogates of inhibitors of blood coagulation factor Xa. , 2004, Bioorganic & medicinal chemistry letters.

[92]  E. Meggers,et al.  Ruthenium complexes as protein kinase inhibitors. , 2004, Organic letters.

[93]  Donald Hamelberg,et al.  DNA sequence dependent monomer-dimer binding modulation of asymmetric benzimidazole derivatives. , 2004, Journal of the American Chemical Society.

[94]  Jean-Pierre Benoit,et al.  Physico-chemical stability of colloidal lipid particles. , 2003, Biomaterials.

[95]  Marc Dellian,et al.  Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[96]  Vladimir P Torchilin,et al.  Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating. , 2002, International journal of pharmaceutics.

[97]  D. Crommelin,et al.  Chemical hydrolysis of DOTAP and DOPE in a liposomal environment. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[98]  R. Cavalli,et al.  Intravenous Administration to Rabbits of Non-stealth and Stealth Doxorubicin-loaded Solid Lipid Nanoparticles at Increasing Concentrations of Stealth Agent: Pharmacokinetics and Distribution of Doxorubicin in Brain and Other Tissues , 2002, Journal of drug targeting.

[99]  R. Neidlein,et al.  Syntheses and reactions of 2,2′-bisbenzimidazole systems , 1999 .

[100]  C. Dunwiddie,et al.  Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGF-receptor tyrosine kinase inhibitor, RPR101511A. , 1999, Circulation.

[101]  T. Kühler,et al.  Structure-activity relationship of 2-[[(2-pyridyl)methyl]thio]-1H- benzimidazoles as anti Helicobacter pylori agents in vitro and evaluation of their in vivo efficacy. , 1998, Journal of medicinal chemistry.

[102]  M. Infante,et al.  Synthesis, Aggregation, and Biological Properties of a New Class of Gemini Cationic Amphiphilic Compounds from Arginine, bis(Args)† , 1996 .

[103]  Y. Barenholz,et al.  Physical (in) stability of liposomes upon chemical hydrolysis: the role of lysophospholipids and fatty acids. , 1995, Biochimica et biophysica acta.

[104]  R. Thummel,et al.  N,N'-Bridged Derivatives of 2,2'-Bibenzimidazole , 1995 .

[105]  T. Mizutani,et al.  Formation of toxic metabolites from thiabendazole and other thiazoles in mice. Identification of thioamides as ring cleavage products. , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[106]  T M Allen,et al.  Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.

[107]  P. Artursson,et al.  Preparation and evaluation of sterically stabilized liposomes: colloidal stability, serum stability, macrophage uptake, and toxicity. , 1990, Journal of pharmaceutical sciences.

[108]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[109]  A. Gabizon,et al.  Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[110]  D. Crommelin,et al.  Stability of Liposomes on Storage: Freeze Dried, Frozen or as an Aqueous Dispersion , 1984, Pharmaceutical Research.

[111]  N. Zhukova,et al.  Advances in the synthesis of benzimidazolones via rearrangements of benzodiazepinones and quinoxalin(on)es , 2017 .

[112]  V. Torchilin,et al.  Targeted delivery of anticancer drugs: new trends in lipid nanocarriers , 2017 .

[113]  P. Cullis,et al.  Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.

[114]  R. Campbell,et al.  Imidazolyl benzimidazoles and imidazo[4,5-b]pyridines as potent p38alpha MAP kinase inhibitors with excellent in vivo antiinflammatory properties. , 2008, Bioorganic & medicinal chemistry letters.

[115]  A. Gubaidullin,et al.  Ring contraction in reactions of 3-benzoylquinoxalin-2-ones with 1,2-phenylenediamines. Quinoxaline-benzoimidazole rearrangement , 2004 .

[116]  E. Lippmann,et al.  Reaktionen mit 3-Chlorochinoxalin-2-carbaldehyd , 1984 .